Cargando…
Ammonium tetrathiomolybdate triggers autophagy-dependent NRF2 activation in vascular endothelial cells
Ammonium tetrathiomolybdate (TTM) is a copper chelator in clinical trials for treatment of Wilson’s disease, tumors and other diseases. In the current study, we innovatively discovered that TTM is a novel NRF2 activator and illustrated that autophagy contributed to TTM-induced NRF2 activation. We sh...
Autores principales: | Zhang, Mengling, Qiu, Hongmei, Mao, Lejiao, Wang, Bin, Li, Na, Fan, Yinzhen, Weng, Ping, Hu, Siyao, Dong, Xiaomei, Qin, Xia, Chen, Chengzhi, Zou, Zhen, Yu, Chao, Zhang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411162/ https://www.ncbi.nlm.nih.gov/pubmed/36008391 http://dx.doi.org/10.1038/s41419-022-05183-z |
Ejemplares similares
-
Reciprocal regulation of NRF2 by autophagy and ubiquitin–proteasome modulates vascular endothelial injury induced by copper oxide nanoparticles
por: Li, Na, et al.
Publicado: (2022) -
PINK1/TAX1BP1-directed mitophagy attenuates vascular endothelial injury induced by copper oxide nanoparticles
por: Fan, Yinzhen, et al.
Publicado: (2022) -
Ammonium tetrathiomolybdate treatment of copper‐associated hepatopathy in dogs
por: Langlois, Daniel K., et al.
Publicado: (2019) -
Ammonium tetrathiomolybdate relieves oxidative stress in cisplatin-induced acute kidney injury via NRF2 signaling pathway
por: Qi, Hao, et al.
Publicado: (2023) -
Is Hydrogen Sulfide a Concern During Treatment of Lung Adenocarcinoma With Ammonium Tetrathiomolybdate?
por: Li, Xiang, et al.
Publicado: (2020)